QORVO Earnings Preview: Recent Insider Trading and Hedge Fund Activity

QORVO, trading under the ticker symbol $QRVO, is set to announce its financial results for the quarter on Monday, November 3rd, following the close of the market, as reported by Finnhub. Analysts have projected revenue of $1,047,731,658 and earnings of $2.07 per share. For comprehensive information on insider trading, hedge fund operations, and congressional trading related to $QRVO, interested individuals can refer to the $QRVO stock page on Quiver Quantitative.

Insiders at QORVO have engaged in open market trading activities regarding $QRVO stock five times within the past half-year. Among these transactions, there have been no acquisitions and five sales of shares. Notable figures include PAUL J FEGO, Senior Vice President of Global Operations, who sold 13,612 shares equating to an estimated value of $1,293,140. Similarly, PHILIP CHESLEY, Senior Vice President of High-Performance Analog, has executed three sales transactions involving 14,039 shares valued at approximately $1,132,877. Furthermore, JOHN R HARDING divested 1,450 shares, estimated to be worth $101,630. To stay updated on insider dealings, refer to Quiver Quantitative’s insider trading dashboard.

With respect to hedge fund activity, there has been notable interest from institutional investors concerning QORVO shares, with 239 entities incorporating shares into their holdings and 241 firms reducing their positions in the most recent quarter. Key movements include prominent adjustments by leading players in the field. For instance, CAPITAL RESEARCH GLOBAL INVESTORS eliminated 1,527,077 shares, equivalent to a 67.7% reduction valued at $129,664,108, during Q2 2025. Similarly, AMUNDI disposed of 1,394,914 shares, reflecting a 68.9% decrease worth $118,442,147, in the same quarter. Notable additions include WOODLINE PARTNERS LP adding 890,031 shares, marking an exponential increase of 30585.3% valued at $75,572,532 in Q2 2025. Detailed insights into hedge fund stock portfolios can be accessed through Quiver Quantitative’s institutional holdings dashboard.

Analysis from Wall Street analysts has revealed recent perspectives on $QRVO, showcasing affirmative sentiments towards the stock, with two firms issuing buy recommendations and zero firms issuing sell calls. Noteworthy ratings encompass an “Overweight” rating from Piper Sandler on 07/30/2025 and a “Buy” rating from Needham on the same date. For updated information on analyst ratings and price projections related to QORVO, individuals can refer to Quiver Quantitative’s $QRVO forecast page.

Various analysts have put forth price targets for $QRVO in recent times, totaling 11 recommendations over the past six months, with a median target of $95.0. Diverse experts have introduced distinct targets, including Atif Malik from Citigroup setting a target price of $105.0 on 10/29/2025, and Timothy Arcuri from UBS establishing a target price of $108.0 on the same date. Cody Acree from Benchmark projected a target price of $125.0 on 07/30/2025, while Christopher Rolland from Susquehanna anticipated a target price of $95.0 on the same day. Additional forecasts came from Ruben Roy at Stifel ($88.0), Quinn Bolton from Needham ($104.0), and Tom O’Malley from Barclays ($90.0) on 07/30/2025. It’s essential to note that the article is not intended as financial advice, and any discrepancies may result from ticker mapping errors and other anomalies.